Displaying items by tag: administration

Wednesday, 08 March 2017 02:12

CAIN & MITNEC Advanced Imaging Networks in Canada

Dr. Jean-Claude Tardif, leader of the CAIN and MITNEC imaging networks, sets the stage with an overview of each network and how they are related. The networks, while varied in focus, strive to overcome key challenges of medical imaging research, learning to harness potential developments to improve clinical practice. As a good primer, this presentation is recommended to all ImagingKT members.

Published in Video

As the Director of the Evaluation of Radiopharmaceuticals and Biotherapeutic Products at Health Canada, Dr. Klein gives a brief background on the introduction of the Food and Drug Act in Canada, followed by a full explanation of the regulatory process for biomarkers in Canada. The regulatory body focuses on the quality, safety and efficacy of diagnostic, preventative and therapeutic agents, being constantly evaluated from first discovery through market use to further evolution and all steps between.

 

 

Published in Video

Taking novel imaging probes from discovery in a lab setting, through full development and on to manufacturing and clinical trials is one of the goals of the MITNEC program and the Centre for Probe Development and Commercialization. Dr. Valliant, the leader of the CPDC and a collaborator in MITNEC outlines each stage in this process, describing all of the steps involved. In particular, new probes in development for imaging neurologic disease are discussed.

Published in Video